Skip to main content
. 2012 Nov 15;12:105. doi: 10.1186/1471-2261-12-105

Table 4.

Characteristics of the study sample of patients stratified according to IMT

 
Normal
Thickening
Plaque
P Values
        ANOVA or χ2 Normal vs Thickening Normal vs Plaque Thickening vs Plaque
Age (years)
47.3 ± 13.3
57.0 ± 9.6
65.9 ± 9.8
<0.001
0.004
<0.001
0.001
Sex (male/female)
16/10
10/12
101/51
0.157
 
 
 
Family history of hypertension (yes/no)
16/10
18/4
79/73
0.026
 
 
 
Family history of stroke (yes/no)
4/22
6/16
29/123
0.564
 
 
 
Smokers (yes/ex/no)
4/3/19
6/2/14
25/37/90
0.242
 
 
 
Diabetes (yes/no)
2/24
1/21
17/135
0.572
 
 
 
Diastolic BP (mmHg)
76.5 ± 10.8
73.4 ± 18.6
75.8 ± 11.1
0.643
1
1
1
Systolic BP (mmHg)
131.5 ± 19.2
124.1 ± 33.2
134.8 ± 21.1
0.106
0.768
1
0.113
Pulse pressure (mmHg)
55.0 ± 14.9
50.6 ± 19.9
59.0 ± 17.8
0.086
1
0.856
0.117
Fasting blood glucose (mmHg)
98.0 ± 20.7
95.7 ± 22.0
104.5 ± 24.7
0.154
1
0.601
0.321
Total Cholesterol (mg/dl)
182.0 ± 38.0
192.0 ± 39.1
185.6 ± 41.4
0.687
1
1
1
BMI (kg/m2)
28.8 ± 5.4
27.3 ± 3.7
27.6 ± 4.6
0.395
0.747
0.596
1
Beta-blockers (yes/no)
15/11
6/16
46/106
0.019
 
 
 
Alphabeta-blockers (yes/no)
1/25
3/19
17/135
0.465
 
 
 
Alpha-blockers (yes/no)
1/25
2/20
13/139
0.702
 
 
 
Diuretics (yes/no)
9/17
8/14
70/82
0.429
 
 
 
ACE inhibitor (yes/no)
10/16
8/14
57/95
0.989
 
 
 
Dihydropyridine (yes/no)
7/19
4/18
41/111
0.675
 
 
 
eGFR (mL/min/1.73 m2)
84.1 ± 17.5
81.2 ± 17.8
75.2 ± 19.1
0.045
1
0.077
0.479
Renal involvement
9/15/2
6/13/3
33/91/28
0.502
 
 
 
IMT (mm)
0.89 ± 0.11
1.19 ± 0.08
2.62 ± 1.61
<0.001
1
<0.001
<0.001
LVMi g/m2
109.6 ± 19.0
126.7 ± 33.2
134.6 ± 30.9
<0.001
0.149
<0.001
0.744
Left Ventricular hypertrophy (no/yes) 20/6 11/11 49/103 <0.001      

Data are expressed as mean and standard deviation for continuous variables (i.e. age) and as number of patients per each group for categorical variable (i.e. gender).

The p-value refers to ANOVA and post-hoc comparison with Bonferroni corrections for continuous variables and to χ2 for categorical variables.